• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ezecor
    / Unipharm


    Active Ingredient
    Ezetimibe 10 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 10 mg

    not in the basket chart 50193

    Dosage

    Adults and adolescents (10 to 17 years of age): The dosage is one tablet (10mg), taken orally, once a day. Ezetimibe can be taken at any hour of the day with or without food with a small amount of water. The tablet can be crushed for immediate use. Cholesterol-lowering diet should be initiated before treatment initiation with this drug and continued during administration of this drug.


    Indications

    Primary hypercholesterolemia: Ezetimibe administered with an HMG-CoA reductase inhibitor (statin) or alone are indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial and non-familial) hypercholesterolemia.
    Homozygous familial hypercholesterolemia (HoFH): Ezetimibe administered with a statin are indicated for use in patients with HoFH.
    Patients may also receive adjunctive treatments (e.g. LDL apheresis).
    Homozygous sitosterolemia (Phytosterolemia): Ezetimibe are indicated for use in patients with homozygous familial sitosterolemia.


    Contra-Indications

    Hypersensitivity to active substance or to its excipients.
    Contomitant use with statin, in patients with hepatic impairment.
    Contomitant use with statin, during pregnancy and lactation.


    Important notes

    Lactose: no content of lactose.


    Manufacturer
    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel
    CLOSE